When it comes to innovation, it’s important to realize that research is a component. At SightMD, we realize this and are currently involved in several studies. Keep reading to learn more!
Studies We Are Currently Involved In
As the director of clinical research at SightMD, I am happy to provide an overview of current studies. These are the studies that SightMD is currently involved with.
I have over 10 years of extensive clinical research experience. I, I am proud to help lead our practice in providing new treatments. The treatments investigated may be available to our patients and the community later on.
As a private practice, SightMD makes it easy for patients to become involved and enrolled. There are no hoops to jump through or barriers, which can be the case in university and academic centers.
Studies We Are Actively Recruiting For
We are currently involved in 2 studies that are actively recruiting. We also have several more in the pipeline.
One of the studies we are focusing on is the use of artificial tears on contact lens discomfort. This study focuses on patients who wear daily contact lenses. The study is looking at whether artificial tears used through the day impact dry eye. symptoms. Patients participating in the study will also receive a stipend.
Another very exciting study we are currently enrolling patients in is a Phase 3 FDA trial. This trial is examining a device (iDose)and intraocular pressure in glaucoma patients. It also involves patients with high intraocular pressure (“ocular hypertension”).
The iDose is an implant inserted into the eye during a short surgical procedure. After insertion, the iDose releases medication to help lower eye pressure for up to 36 months.
This is a ground-breaking treatment for glaucoma and ocular hypertension! We are very excited about helping our patients and getting others involved! Patients involved in this study will also receive stipends for each visit.
Studies We Will Begin Recruiting For
Other studies we will begin recruiting for include:
Trifocal intraocular lens placement during cataract surgery:
We will examine the success of this new, advanced technology. The trifocal intraocular lens is to help improve vision post-cataract surgery.
Intranasal neurostimulation for dry eye:
Patients with severe dry eye ( neurotrophic keratitis) may get relief from intranasal neurostimulation. This is a device that provides impulses to the nerves inside the nose. The nerves then produce natural tears.
Treatment of Demodex:
We will be investigating the treatment of a certain type of eyelash mite. We will do this by using medicated wipes and an eyelid cleansing system.
I hope we can work together to enhance eye care via clinical research. Access to clinical studies can be life-changing for patients. We are excited and proud to offer these opportunities within our practice.
If you have any interest in any of the above research projects, know someone who may be, or have any questions, please do not hesitate to reach out to myself, and Heather McBride.
Alanna Nattis, DO FAAO: ANATTIS@SIGHTMD.COM
HEATHER MCBRIDE: HMCBRIDE@SIGHTMD.COM